<DOC>
	<DOCNO>NCT02275546</DOCNO>
	<brief_summary>The purpose study assess performance safe use vaginal ring applicator optional aid insertion placebo vaginal ring vagina healthy woman</brief_summary>
	<brief_title>Performance Safety Vaginal Ring Applicator Healthy Females ( MK-8342A-063 )</brief_title>
	<detailed_description />
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Desogestrel</mesh_term>
	<criteria>healthy , nonpregnant , premenopausal female use NuvaRing . must meet one two follow criterion : 1 ) take combined hormonal contraceptive least 3 month prior screen normal predictable menstrual cycle range 26 35 day length history intermenstrual bleeding past 6 month ; 2 ) taking combine hormonal contraceptive &gt; 3 month experience unscheduled bleeding past 3 month . willing abstain vaginal penetration , include sexual intercourse masturbation , time randomization ( Visit 2 ) end followup period . willing abstain vaginal penetration object applicator placebo ring ( include limited tampon , douche , use vaginal applicator medication , medication , diaphragm , cervical cap , male female condom , lubricant , sex toy ) time randomization ( Visit 2 ) end followup period . good physical mental health , base upon medical judgment investigator . current use use within past 3 month follow : NuvaRing , progestinonly contraceptive ( include pill , injection , implant ) , oral transdermal combine hormonal contraceptive extend continuous hormonal regimen prevent monthly withdrawal bleed omit monthly progestinfree interval . Note : Current use oral transdermal combine hormonal contraceptive 4 7 progestinfree day per 28day cycle &gt; 3 month permit . stop use hormonal contraceptive , include NuvaRing , &lt; 3 month prior screen ; previous use ( â‰¥3 month prior screen ) permit . history difficulty retain NuvaRing vagina therefore could continue contraceptive method difficulty retain product ( e.g. , tampon ) vagina . pregnant within 2 month last pregnancy outcome ( delivery , spontaneous induced abortion , medical surgical management ectopic pregnancy ) . breastfeed . diagnose treat sexually transmitted disease within past 6 month . current complaint vaginal vulvar irritation , discomfort , abnormal bleeding/spotting , abnormal discharge . abnormal cervical Pap smear document within 12 month screen . genital herpes outbreak past 3 year . receive investigational drug device 30 day prior screen and/or plan receive investigational drug device time last protocolrequired visit . know current gynecological disorder , opinion investigator , interfere objective study . know allergy/sensitivity contraindication investigational product ( applicator ) ethylene vinyl acetate . current recent history ( within last six month ) drug alcohol abuse dependence .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>